FDA Clears Jointechlabs’ MiniTC for Point-of-Care Fat Tissue Processing and its Broad Range of Applications Sep 3, 2020 | News Jointechlabs – a leader in point-of-care regenerative medicine therapies – announced that the U.S. Food and Drug Administration (FDA) cleared theThis content is restricted to site members. If you are an existing user, please log in. New users may register below.New User RegistrationFirst Name*Last Name*Job Title*Aesthetic PhysicianAnti-Ageing PhysicianCEO / Senior Partner / DirectorClinic and Medical Spa ManagerCosmetic SurgeonDermatologistDoctor or ConsultantEndocrinologistGynaecologistPlastic SurgeonOtherEmail*Choose a Username*Do you wish to receive FREE digital copies of PRIME and Subscribe to PRIME Newsletter?* Yes NoDo you wish to receive printed copies of PRIME? (€180 per annum)* Yes NoWould you like to receive occasional offers from other select Informa Group and third parties?* Yes NoAddress 1*Address 2City*StateZip*Country*Password*Confirm Password* Please indicate that you agree to the Terms of Service **Required field